Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Investigator-blinded, controlled, and randomized comparative study on 1565 nm non-ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia

Our data demonstrate that 1565 nm NAFL exhibits superior clinical efficacy in some aspects of hair growth to the topical minoxidil. It is a safe and effective modality in treating AGA.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors randomly assigned 30 patients with androgenetic alopecia to 1565 nm non-ablative fractional laser treatment or 5% topical minoxidil. They report that both treatments increased hair density and diameter by week 10, and that the laser showed greater improvements than minoxidil in several hair count measures. The authors describe the laser as safe and effective for this condition.

Participants
30
Who or what was studied
Patients with androgenetic alopecia (30 enrolled, randomly assigned to laser or minoxidil groups)
Wavelengths
1565 nm
Limits stated in the abstract
The abstract describes a small randomized sample of 30 patients and reports outcomes at a single 10-week time point.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

Characterized by progressive hair loss due to an excessive response to androgens, androgenetic alopecia (AGA) affects up to 50% of males and females. Minoxidil is one of approved medications for AGA but inadequate responses occur in many patients.

Aims

To determine whether 1565 nm non-ablative fractional laser (NAFL) could yield better therapeutic benefits for patients with AGA as compared with 5% minoxidil.

Methods

Thirty patients with AGA were enrolled; they were randomly assigned into the laser or minoxidil treatment groups. For the laser treatment group, patients were treated by 1565 nm NAFL at 10 mJ, 250 spots/cm2 with 2 weeks intervals for 4 sessions in total. For the minoxidil treatment group, 1-milliliter of topical 5% minoxidil solution was applied to hair loss area twice a day.

Results

The primary outcomes were the changes in numerous hair growth indexes at the Week 10 as compared with the baselines. Both 1565 nm NAFL and 5% minoxidil led to significantly greater hair densities and diameters in patients at the Week 10 than the baselines (p < 0.01). As compared with 5% minoxidil, 1565 nm NAFL showed significantly greater improvements in total hair number, total hair density (hair/cm2), terminal hair number, terminal hair density (hair/cm2), number of hair follicle units, and average hair number/number of hair follicle units.

Conclusions

Our data demonstrate that 1565 nm NAFL exhibits superior clinical efficacy in some aspects of hair growth to the topical minoxidil. It is a safe and effective modality in treating AGA.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
1565 nm

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Laser, Androgenetic alopecia, Light-emitting diode. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Skin & Wound Healing

A hybrid 755-nm/1064-nm dual-wavelength laser compared with a single 755-nm alexandrite laser for hair reduction: a prospective, single-blind, split-body controlled trial with alternating allocation

No device-related adverse events occurred at hybrid-mode sites. The synchronized hybrid 755-nm/1064-nm mode produced superior hair-thickness reduction compared with single 755-nm treatment, with comparable satisfaction and favourable tolerability.

Study · October 1, 2026 · Baek NY et al.